These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19853183)

  • 1. Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections.
    Doeberitz Mv; Vinokurova S
    Arch Med Res; 2009 Aug; 40(6):435-42. PubMed ID: 19853183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic response to (pre)neoplastic cervical lesions associated with human papillomavirus].
    Delvenne P
    Bull Mem Acad R Med Belg; 2005; 160(5-6):287-93. PubMed ID: 16465783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccines: preclinical development.
    Gissmann L
    Arch Med Res; 2009 Aug; 40(6):466-70. PubMed ID: 19853186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiology of human papillomavirus.
    Prasad CJ
    Clin Lab Med; 1995 Sep; 15(3):685-704. PubMed ID: 8542729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the biological behaviour of cervical human papillomavirus (HPV) infections in prospectively followed-up women.
    Syrjänen K; Mäntyjärvi R; Väyrynen M; Holopainen H; Saarikoski S; Castrén O
    Arch Geschwulstforsch; 1985; 55(6):457-66. PubMed ID: 3002294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin E expression by normal and premalignant cervical epithelium.
    Mota F; Kanan JH; Rayment N; Mould T; Singer A; Chain BM
    Am J Pathol; 1997 Apr; 150(4):1223-9. PubMed ID: 9094979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do "high-risk" human papillomavirus (HPV) types lead to cancer by evading the immune system?
    Tendler A; Ho GY; Kadish AS
    Gynecol Oncol; 1999 Apr; 73(1):169-70. PubMed ID: 10094902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracutaneous test for detection of cellular immune reactions to HPV-16 proteins in patients with CIN].
    Heim K; Höpfl R; Sandbichler M; Sepp N; Wartusch B; Müller-Holzner E; Jochmus-Kudielka I; Ter Meulen J; Gissmann L; Fritsch P
    Gynakol Rundsch; 1991; 31 Suppl 2():220-3. PubMed ID: 1665135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proliferating cell nuclear antigen in precancerous cervical disease].
    Frank GA; Minkina GN; Kulagina LA; Simonova TV; Petrov AN
    Arkh Patol; 1997; 59(1):30-3. PubMed ID: 9139604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of viral infection with human papillomavirus-HPV in carcinogenesis of the uterine cervix].
    Kwaśniewska A
    Postepy Hig Med Dosw; 1997; 51(5):547-65. PubMed ID: 9489454
    [No Abstract]   [Full Text] [Related]  

  • 12. p16INK4A expression in cervical premalignant and malignant lesions.
    Lambert AP; Anschau F; Schmitt VM
    Exp Mol Pathol; 2006 Apr; 80(2):192-6. PubMed ID: 16257403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of gynecological conditions in women.
    Proj Inf Perspect; 1998 Sep; (25):15. PubMed ID: 11365842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clearance, persistence and recurrence of HPV infection].
    Denis F; Hanz S; Alain S
    Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
    Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between human papillomavirus DNA in the lymph nodes and metastasis of early-stage cervical carcinoma].
    Sun Y; Liu GB; Yu YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):796-8. PubMed ID: 18504207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The incidence of papillomavirus types 6/11 and 16/18 in cervix smears].
    Wartusch B; Müller-Holzner E; Weiss D; Heim K; Holböck E; Fuith L
    Gynakol Rundsch; 1989; 29 Suppl 2():79-81. PubMed ID: 2558998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.